Current POSITION
from 2017 to present
Full Professor of Medicinal Chemistry, NEUROFARBA Department, University of Florence, Italy
WORK EXPERIENCE
from 2014 to 2017
Associate Professor of Medicinal Chemistry
NEUROFARBA Department, University of Florence, Italy
from 2012 to 2014
Assistant Professor of Medicinal Chemistry
from 2006 to 2012
Research Professor
Chemistry Department, University of Florence, Italy
from 2001 to 2006
Research Fellow
from 1995 to 1998
Marie Curie Post-doc Fellow
from 1991 to 1994
Associate Professor
Chemistry Department, University of Bucharest, Romania
from 1990 to 1991
Assistant Professor
EDUCATION AND TRAINING
from 1998 to 2001
PhD in Chemistry
from 1988 to 1991
Polytechnic University of Bucharest, Department of Chemistry, Romania
LANGUAGE(S)
Mother tongues
Italian, Romanian
Other language(s)
UNDERSTANDING
SPEAKING
WRITING
Listening
Reading
Spoken interaction
Spoken production
English
Excellent
French
Good
German
FELLOWSHIPS AND AWARDS
2008
2010
2016
2016 / 2017
2018
2020
2017
1991
1980
Sir John W. Sewell visiting fellow at Eskitis Institute, Griffith University, Brisbane, Australia
Visiting scientist, Dept. Chemistry Università La Plata, Argentina,
Visiting fellow at the Dept. of Chemistry, Univ. of New South Wales, Sydney, Australia
Visiting professor at Federal Univ. of Rio De Janeiro, Inst. of Microbiology, Rio de Janeiro, Brasil
Pratesi Medal of Italian Chemical Society for merit in Medicinal and Pharmaceutical Chemistry
Gold medal at the International Olympiad of Chemistry, Bourgas, Bulgaria.
Bronze medal at the International Olympiad of Chemistry, Linz, Austria.
TEACHING ACTIVITIES
from 2014 to 2018
from 2018 to present
Analysis of Drugs, SFA – CQ, University of Florence
Pharmaceutical Chemistry Part II, Pharmacy, University of Florence
ORGANISATION OF SCIENTIFIC MEETINGS
2003
2006
2009
2012
2013
2015
2022
6th International Carbonic Anhydrase conference, Smolenice (Bratislava), Slovakia
9th International Conference of Metal Ions in Biological Systems, Lisbon, Portugal
31th FEBS meeting, Istanbul, Turkey
8th International Carbonic Anhydrase conference, Florence, Italy
9th International Carbonic Anhydrase conference, Antalya, Turkey
2nd Carbonic anhydrase satellite meeting, Naples, Italy
10th International Carbonic Anhydrase conference, Maastricht, The Netherlands
3rd Carbonic anhydrase satellite meeting, Montecatini Terme, Italy
11th International Carbonic Anhydrase conference, Bucharest, Romania
National Italian Chemical Society meeting for young researchers, Florence, Italy
4th International Symposium on Frontiers in Molecular Sciences, Florence, Italy
INSTITUTIONAL ROLES
from 2012 to present
from 2014 to present
Faculty member, NEUROFARBA Dept., University of Florence, Italy
Graduating Student Advisor, NEUROFARBA Dept., University of Florence, Italy
PhD Committee member, NEUROFARBA Dept., University of Florence, Italy
Organizer of the Internal Seminars, NEUROFARBA Dept., University of Florence, Italy
REVIEWER/EDITOR ACTIVITY
from 2005 to present
from 2011 to present
Editorial Board member of the following journals: Medicinal Research Reviews; ACS Med Chem Lett, European Journal of Medicinal Chemistry, Bioorganic and Medicinal Chemistry Letters, Bioorganic and Medicinal Chemistry, Current Medicinal Chemistry, Molecules, Current Pharmaceutical Design, Current Organic Chemistry, Metal Based Drugs, Turkish Journal of Biochemistry, Marine Drugs, Molecular Recognition, Applied Organometallic Chemistry, Current Topics in Medicinal Chemistry; Metabolites, Pathogens.
Editor in Chief: Journal of Enzyme Inhibition and Medicinal Chemistry
Editor in Chief: Expert Opinion on Therapeutic Patents
Editor in Chief International Journal of Molecular Sciences
MEMBERSHIPS OF
SCIENTIFIC SOCIETIES
from 2002 to 2007
American Chemical Society, USA
Italian Chemical Society, Italy
Relevant Publications
Patents
Research monographs
published in the last 10 years
Lectures as invited
speaker in the following events/institutions
Oxford, UK (2008); Namur, Belgium (2007); Brisbane, Australia (2008); Gold Coast, Australia (2008); Bucharest, Romania (2008); Vilnius, Lithuania (2008); Riga, Latvia (2008); Canterbury, UK (2008); Monte Carlo, Monaco (2008); Nice, France (2009); Ankara, Turkey (2009); Copenhagen, Denmark (2009); Giresun, Turkey (2009), Trabzon, Turkey (2009); Frankfurt, Germany (2009); Manchester, UK (2009); La Plata, Argentina (2010); Aachen, Germany (2010); Cairo, Egypt (2010); Reims, France (2010); Jerusalem, Israel (2010); Antalya, Turkey (2010); Luxor, Egypt (2010); Erzurum, Turkey (2011); Madrid, Spain (2011); Santiago de Compostela, Spain, (2011); Toulouse, France (2012); Antalya, Turkey (2012); Ankara, Turkey (2012); Munchen, Germany (2013); Rome, Italy (2013); Marseille, France (2014); Siena, Italy (2014); Brisbane, Australia (2014); Maastricht, The Netherlands (2015); Siena, Italy (2015); Riga, Latvia (2015; Istanbul, Turkey (2015); Venezia, Italy (2015); Paris, France (2016); Antalya, Turkey (2016); Perugia, Italy (2016); Ischia, Italy (2016); Bucharest, Romania (2016); Adelaide, Australia (2016); Sydney, Australia (2016); Rio de Janeiro, Brasil (2016); Montecatini, Italy (2017); Paestum, Italy (2017); Wollongong, Australia (2018); Bucharest, Romania (2018); Iasi, Romania (2019); Parma, Italy (2019); Wollongong, Australia (2020); Sydney, Australia (2020); Atlanta, USA (2021); Rio De Janeiro, Brazil (2021); Jeddah, Saudi Arabia (2022).
Major collaborations
Industrial innovation/collaboration
A sulfonamide carbonic anhydrase inhibitor discovered in my laboratory, SLC-0111, completed Phase I clinical trials as antitumor/antimetastatic agent in 2014 and is presently in Phase Ib/II clinical trials in Canada, being developed by Welichem Biotech Inc., for the treatment of advanced, metastatic solid tumors (FDA identifier number: NCT03450018).
See also: https://clinicaltrials.gov/ct2/show/NCT03450018.
I collaborated with the major world drug companies in various projects involving carbonic anhydrase inhibitors, among which: Solvay Pharmaceuticals (Hannover, Germania) – 1999- 2006; Pfizer (Groton, USA) – 2000 – 2002; Pharmacia, St. Louis, USA – 2002-2003; Nicox (Nice, France) – 2004 – 2006; IRBM/Merck (Pomezia, Italy) – 2005 – 2006; Merck KgA (Darmstadt, Germany) – 2006 – 2007; Inotek Pharmaceuticals. Ra’anana, Israel and Boston, MA (USA): 2007- 2008; Bayer-Schering Pharma, Berlin (Germany): 2006 – 2008; Morphotek, Cambridge, MA (USA): 2009 – 2011; Gruenenthal, Aachen, Germany: 2010 – 2011; PerkinElmer, Boston, MA (USA): 2010-2011; Merck, Sharp and Dohme, Rahway (USA), 2012; Pierre Fabre, Toulouse (France): 2012-2013; Signal Life Sciences & Co., Vancouver (Canada): 2014-2018; L'Oréal, Paris (France): 2015-2020.
Track Record (Scopus)
publications
citations
h-index
> 1900
110036 (Google Scholar)
156
The >45 papers on obesity are found at this link: https://pubmed.ncbi.nlm.nih.gov/?term=supuran%2C+obesity&sort=date
>125000 (Google Scholar)
> 2000
> 125000
164
Legenda
